GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
NASDAQ:GDRX - Nasdaq - US38246G1085 - Common Stock
We assign a fundamental rating of 5 out of 10 to GDRX. GDRX was compared to 39 industry peers in the Health Care Technology industry. GDRX has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on GDRX. This makes GDRX very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year GDRX was profitable.
In the past year GDRX had a positive cash flow from operations.
GDRX had negative earnings in 4 of the past 5 years.
GDRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
GDRX has a better Return On Assets (-1.20%) than 83.78% of its industry peers.
GDRX has a better Return On Equity (-2.33%) than 83.78% of its industry peers.
The Return On Invested Capital of GDRX (1.88%) is better than 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.2% | ||
| ROE | -2.33% | ||
| ROIC | 1.88% |
ROA(3y)-1.39%
ROA(5y)-1.42%
ROE(3y)-2.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GDRX's Operating Margin of 3.74% is fine compared to the rest of the industry. GDRX outperforms 75.68% of its industry peers.
With an excellent Gross Margin value of 93.52%, GDRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.74% | ||
| PM (TTM) | N/A | ||
| GM | 93.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.26%
GM growth 5Y-1.37%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GDRX is destroying value.
GDRX has less shares outstanding than it did 1 year ago.
GDRX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for GDRX is higher compared to a year ago.
2.2 Solvency
GDRX has an Altman-Z score of 1.20. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.20, GDRX is in line with its industry, outperforming 56.76% of the companies in the same industry.
The Debt to FCF ratio of GDRX is 5.55, which is a neutral value as it means it would take GDRX, 5.55 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.55, GDRX is doing good in the industry, outperforming 64.86% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that GDRX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.70, GDRX is doing worse than 72.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | 5.55 | ||
| Altman-Z | 1.2 |
ROIC/WACC0.19
WACC9.86%
2.3 Liquidity
GDRX has a Current Ratio of 5.48. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.48, GDRX belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
GDRX has a Quick Ratio of 5.48. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
GDRX has a Quick ratio of 5.48. This is amongst the best in the industry. GDRX outperforms 91.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.48 | ||
| Quick Ratio | 5.48 |
3. Growth
3.1 Past
GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.52%, which is quite good.
The Revenue has been growing slightly by 7.13% in the past year.
The Revenue has been growing by 24.63% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)7.13%
Revenue growth 3Y10.86%
Revenue growth 5Y24.63%
Sales Q2Q%8.5%
3.2 Future
The Earnings Per Share is expected to grow by 21.27% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.60% on average over the next years.
EPS Next Y24.95%
EPS Next 2Y20.68%
EPS Next 3Y20.65%
EPS Next 5Y21.27%
Revenue Next Year5.44%
Revenue Next 2Y4.74%
Revenue Next 3Y5.93%
Revenue Next 5Y6.6%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 14.28 indicates a correct valuation of GDRX.
Based on the Price/Earnings ratio, GDRX is valued cheaply inside the industry as 94.59% of the companies are valued more expensively.
GDRX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.96.
A Price/Forward Earnings ratio of 11.21 indicates a reasonable valuation of GDRX.
97.30% of the companies in the same industry are more expensive than GDRX, based on the Price/Forward Earnings ratio.
GDRX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.11.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.28 | ||
| Fwd PE | 11.21 |
4.2 Price Multiples
GDRX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GDRX is cheaper than 86.49% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 81.08% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.69 | ||
| EV/EBITDA | 14.64 |
4.3 Compensation for Growth
GDRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GDRX's earnings are expected to grow with 20.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y20.68%
EPS Next 3Y20.65%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GOODRX HOLDINGS INC-CLASS A
NASDAQ:GDRX (1/17/2025, 8:03:29 PM)
After market: 4.6 +0.03 (+0.66%)4.57
+0.15 (+3.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners60.62%
Inst Owner Change-0.03%
Ins Owners12.28%
Ins Owner Change12.29%
Market Cap1.74B
Analysts75.83
Price Target7.29 (59.52%)
Short Float %8.47%
Short Ratio4.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.6%
Min EPS beat(2)-10.15%
Max EPS beat(2)-9.04%
EPS beat(4)2
Avg EPS beat(4)0.37%
Min EPS beat(4)-10.15%
Max EPS beat(4)16.19%
EPS beat(8)6
Avg EPS beat(8)11.07%
EPS beat(12)9
Avg EPS beat(12)18.26%
EPS beat(16)11
Avg EPS beat(16)14.54%
Revenue beat(2)0
Avg Revenue beat(2)-2.02%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)-1.06%
Revenue beat(8)1
Avg Revenue beat(8)-1.65%
Revenue beat(12)2
Avg Revenue beat(12)-1.4%
Revenue beat(16)3
Avg Revenue beat(16)-1.24%
PT rev (1m)-1.62%
PT rev (3m)-25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.28 | ||
| Fwd PE | 11.21 | ||
| P/S | 2.2 | ||
| P/FCF | 19.69 | ||
| P/OCF | 11.23 | ||
| P/B | 2.5 | ||
| P/tB | 15.59 | ||
| EV/EBITDA | 14.64 |
EPS(TTM)0.32
EY7%
EPS(NY)0.41
Fwd EY8.92%
FCF(TTM)0.23
FCFY5.08%
OCF(TTM)0.41
OCFY8.9%
SpS2.07
BVpS1.83
TBVpS0.29
PEG (NY)0.57
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.2% | ||
| ROE | -2.33% | ||
| ROCE | 2.38% | ||
| ROIC | 1.88% | ||
| ROICexc | 2.86% | ||
| ROICexgc | 10.06% | ||
| OM | 3.74% | ||
| PM (TTM) | N/A | ||
| GM | 93.52% | ||
| FCFM | 11.19% |
ROA(3y)-1.39%
ROA(5y)-1.42%
ROE(3y)-2.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.26%
GM growth 5Y-1.37%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | 5.55 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 70.81% | ||
| Cap/Sales | 8.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 125.48% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.48 | ||
| Quick Ratio | 5.48 | ||
| Altman-Z | 1.2 |
F-Score6
WACC9.86%
ROIC/WACC0.19
Cap/Depr(3y)84.55%
Cap/Depr(5y)98.02%
Cap/Sales(3y)6.42%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y24.95%
EPS Next 2Y20.68%
EPS Next 3Y20.65%
EPS Next 5Y21.27%
Revenue 1Y (TTM)7.13%
Revenue growth 3Y10.86%
Revenue growth 5Y24.63%
Sales Q2Q%8.5%
Revenue Next Year5.44%
Revenue Next 2Y4.74%
Revenue Next 3Y5.93%
Revenue Next 5Y6.6%
EBIT growth 1Y293.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.99%
EBIT Next 3Y21.41%
EBIT Next 5Y17.2%
FCF growth 1Y-23.4%
FCF growth 3Y-4.75%
FCF growth 5Y14.57%
OCF growth 1Y-5.86%
OCF growth 3Y1.74%
OCF growth 5Y25.01%